Confused about the New DuPont? Forbes has an analysis

The business publication asks: "How does DuPont make money?"

Life sciences.

(Photo by Pexels user Martin Lopez used under a Creative Commons license)

DuPont has changed a lot in the last five years.

The Dow/DuPont merger in some ways changed the landscape of Wilmington, as the company as we knew it seemed to dissolve, change, and, after the Dow/DuPont split earlier this year (Q2), make a comeback as the “New” DuPont.

What is the new DuPont and how is it different from the old DuPont? Forbes has created an interactive data analysis on Trefis called “DuPont’s Revenues: How does DuPont make money?

The short answer, according to the analysis: Nutrition and Biosciences is DuPont’s largest segment, bringing in about 30% of its $21 billion in revenue in 2019 (note that this segment may be changing hands or merging soon, as the company is currently courting bids for it.) The other segments are Transportation & Advance Polymers (26.1%), Safety & Construction (25.3%) and Electronics & Imaging (18.3%).

While DuPont’s Nutritonal Unit develops chemicals for food preservation, a large part of what it produces are probiotics, cultures and soy-based food products. This unit has driven the most growth in 2018, but a drop of 6% is predicted in 2019.

The largest predicted drop, according to the Trefis analysis, is the Electronics and Imaging segment, which is estimated to drop by 18% in 2019.

The analysis includes information about DuPont’s business model and the focus of each segment. You can access the analysis here —and create your own forecasts if you don’t agree with Forbes’ assessment.

Companies: DuPont
Subscribe to our Newsletters
Technically Media
Connect with companies from the community
New call-to-action